|2/28/2018 4:51 PM||Updates on Recovery House Licensing|
|2/27/2018 4:35 PM||Febraury 2018 ASAM Transition Update|
|2/16/2018 11:51 AM||SAMHSA Releases Clinical Guidance to Help Enhance Understanding of Medications to Treat Opioid Use Disorder|
The Substance Abuse and Mental Health Services Administration (SAMHSA) recently published new clinical guidance to help expand health care professionals' knowledge of medications used to help treat opioid use disorder. Treatment Improvement Protocol (TIP) 63 details methadone, naltrexone, and buprenorphine, all three of which are FDA-approved to treat opioid use disorder.
TIP 63 is available to order and download at www.samhsa.gov.
|1/10/2018 10:41 AM||Office Relocation|
Valued Stakeholders and Council Members,
As some of you may know, staff from the Department of Drug
and Alcohol Programs has been spread across three different Harrisburg offices
since we officially became a department in 2012. Beginning January 16, the department’s
employees working in Harrisburg will move into One Penn Center located at 2601
N. Third Street in Harrisburg.
We are all very excited to operate in a new space under one
roof, and I speak for many of us by saying that I look forward to new opportunities
for collaboration and productivity that will come from working in one space. Phone
numbers and other email contact information for the department will remain the
same after the move, and staff will be in touch with changes to their
individual mailing addresses.
Department staff is currently hard at work packing their
current spaces, and the move will officially begin Thursday, January 11. During
this period, we may experience technical disruptions and be inaccessible by
phone or email for periods of time. Staff will do their best to return messages
as quickly as possible, but we appreciate patience as we make this significant
change and settle into the new office space.
I look forward to welcoming you all to this space, which
includes a large space for in-person training opportunities. Again, I
appreciate your patience and consideration as we make this transition.
|12/29/2017 8:38 AM||DDAP New Feature - More on Mondays|
|12/22/2017 11:04 AM||Synar Announcement|
The Department of Drug and Alcohol Programs has prepared the
2018 Annual Synar Report which is available for review by visiting Substance Abuse
Prevention and Treatment Block (SAPTB) Grant -- To view
Pennsylvania's SAPTB grant application and reporting, enter
"citizenpa" for the user name and "citizen" for the
|12/22/2017 9:10 AM||2018 Annual Synar Report |
The Department of Drug and Alcohol Programs has prepared the 2018 Annual Synar Report which in now available for review.
|12/11/2017 8:35 AM||Save the Date Flyer for the 2018 PA CARES Training Summit, May 2018. |
Attached please find a Save the Date Flyer for the 2018 PA CARES Training Summit. The training summit will take place in May 2018 in Elizabethtown, PA. More information including registration details will be forthcoming.
|11/22/2017 12:26 PM||ASAM Criteria Transition|
Attached please find correspondence from Acting Secretary Jennifer Smith regarding the ASAM Criteria transition as well as an ASAM FAQ.
|11/16/2017 9:54 AM||New Training Material about Women Veterans Released|
Women are enlisting in the U.S. military at an unprecedented rate. They currently make up around 16 percent of the active duty force, which is the highest rate since the all volunteer force went into effect in 1973. In addition, there are approximately 2 million women veterans in America.
We thank those who have valiantly served our country through the military, and we strive to meet the continuing needs of veterans.
To help behavioral health providers better serve women veterans, the Substance Abuse and Mental Health Services Administration (SAMHSA) just released additional material for the Training Tool Box for Addressing the Gender-specific Service Needs of Women with Substance Use Disorders that focuses on this population. The Training Tool Box is a resource that:
- Serves as a launching board that trainers can use to develop informative, evidence-based trainings about the gender-specific needs of women with substance use disorders (SUDs); and
- Enables trainers to customize workforce learning through fully designed PowerPoint slides, talking points, activities, case studies, resources, and references.
The new supplemental slides can be used to better educate the workforce about women veterans who have SUDs. Featured topics include characteristics of women veterans and current service members, protective and risk factors for SUDs, the needs of women veterans, and recommendations for providers who serve women veterans.
Other related educational resources available on the website include the following:
- Relationships Matter! a webinar series on women's behavioral health that explores the role of relationships in the lives of women experiencing mental health and substance use issues;
- Women Matter! a webinar series that presents current research, best practice, and critical thinking about topics professionals need to know when working with women who have substance use disorders;
- Girls Matter! a webinar series that offers research, best practices, and critical thinking on topics that professionals working with girls and young women must know; and
- Introduction to Women and Substance Use Disorders, a 12-hour, self-paced course developed by SAMHSA that helps counselors and other practitioners working with women better understand women's substance use, treatment, and recovery experiences and effective interventions for women.
All four of these resources provide the option for continuing education credits and can be found on the SAMHSA Women, Children, and Families Training and Technical Assistance website's Trainings page.
We honor all veterans today and thank them for their service!
|10/10/2017 4:02 PM||Workshop: You Are Not Alone: A Workshop for Families Affected by Substance Use and Addiction|
This is a free family workshop coming up on October 14
sponsored by Bridge To Hope and Passavant Hospital Foundation. Below are
links to information on the seminar:
|8/16/2017 12:10 PM||Preventing Occupational Fentanyl and Fentanyl Analog Exposure to Emergency Responders|
The position of the American College of Medical Toxicology
(ACMT) and American Academy of Clinical Toxicology (AACT), is as follows:
Fentanyl and its analogs are potent opioid receptor agonists, but the risk of
clinically significant exposure to emergency responders is extremely low. To
date, we have not seen reports of emergency responders developing signs or
symptoms consistent with opioid toxicity from incidental contact with opioids.
|7/26/2017 12:49 PM||Policy Bulletin 17-02 - DDAP Prevention Manual Modifications|
Please see attached Policy Bulletin 17-02.
|7/7/2017 1:47 PM||June Edition - The Phoenix Newsletter|
|6/19/2017 9:51 AM||Policy Bulletin 17-01: Historical TEDS Data Entry in PA WITS|
See attached for Policy Bulletin 17-01
|6/19/2017 9:45 AM||Medical Assistance Application Guide|
|5/31/2017 3:01 PM||DDAP Monthly Newsletter|
|5/22/2017 3:49 PM||PA WITS|
Today the Department of Drug and Alcohol Programs (DDAP) announced the official go-live for the new DDAP Data System (PA WITS).
You can stream / download today’s webcast using the links below:
Additional information on PA WITS including: Training, policy bulletin and the Business Associated-Qualified Service Organization Agreement (a.k.a. BAQSOA or QSOA) providers must enter into with FEi can be found at
Signed BAQSOAs should be returned to FEi, Inc at:
• Fax: 410-715-6538
Once FEi receives the agreement, they will activate all of the users for that agency based on the list of user accounts the provider compiled for DDAP several months ago. Users will get an automated email to set up their account.
|5/17/2017 12:58 PM||PA WITS Go-Live Kick Off |
The Department of Drug and Alcohol
Programs (DDAP) is excited to announce the official go-live for the new DDAP Data System (PA WITS) on May
22, 2017. This version of the PA WITS system is being implemented
two-months ahead of schedule for the purposes of collecting TEDS data since
September 1, 2015.
We invite you to join a live streaming
webcast to kick-off the first day of your access to PA WITS. The webcast
will be presented by DDAP project leaders covering important topics
including: policy requirements, e-Training, and how to gain access.
The webcast will be recorded and available for viewing at a later date.
|4/26/2017 11:21 AM||Availability of Free Grief Support Groups|
A PA Advisory Council on Drug and Alcohol
Abuse subcommittee is compiling information on the availability of free
grief support groups statewide that are specifically
tailored for parents, siblings, spouses, etc. that have lost a loved
one to addiction. If you are aware of any such groups, please send the
information to Council member Jennifer Zampogna at firstname.lastname@example.org.
|4/14/2017 9:58 AM||Webinar on the American Society of Addiction Medicine’s (ASAM) Criteria for Clinical and Program Standards |
Centers for Medicare and Medicaid Services (CMS) is hosting a webinar entitled
“Introduction to the American Society of Addiction Medicine (ASAM) Criteria for
Clinical and Program Standards.” The webinar will provide an overview of the
substance use disorder treatment care continuum and standards described in the
American Society of Addiction Medicine (ASAM) Criteria. The webinar will
provide an overview of all the ASAM Criteria levels of care, and then focus
specifically on complex levels of care, including withdrawal management, early
intervention, partial hospitalization, and clinically managed low-intensity
residential services. The webinar will be held on Wednesday, April 19th
from 3:30pm– 5:00pm EST.
for the webinar here.
|4/12/2017 8:19 AM||Frequently Asked Questions |
In preparing for the statewide transition from the
Pennsylvania Client Placement Criteria (PCPC) to the American Society of
Addiction Medicine (ASAM) Criteria, DDAP has prepared the attached list of
Frequently Asked Questions which is also available on its website at the
following location: http://www.ddap.pa.gov/treatment/Pages/ASAM_FAQ.aspx
. Additional questions that are not currently addressed by the FAQ can be
submitted to RA-DATREATMENT@pa.gov
and updates will be made to the website on a regular basis.
|4/6/2017 2:43 PM||DEA National Prescription Drug Take-Back Day - Toolkit Available|
The new toolkit of fliers, posters, brochures, Web ads, and other materials that are typically made available to help advertise the DEA’s National Prescription Drug Take-Back Day is now live at https://www.dea.gov/take-back/takeback-news.shtml. The material is under the “Partnership Toolbox” button on the right-hand side.
Please feel free to pass this info along to your partnering organizations in drug abuse prevention so they can use these toolkit items, push them out to others, and help spread the word about the upcoming take-back day on April 29.
|3/16/2017 7:16 AM||SECRETARY SMITH’S ANNOUNCEMENT REGARDING TRANSITION FROM THE PCPC TO THE ASAM:|
DDAP has, in consultation with the Governor’s Policy Office and the Office of General Counsel, weighed our options for continuing the use of our PCPC (Pennsylvania Client Placement Criteria) tool for determining the appropriate level of care for an individual seeking treatment or already within our treatment system. After weighing the options, we have decided that the benefits of using a customized tool no longer exceed the benefits of using the nationally recognized ASAM (American Society of Addiction Medicine) tool. One reason for the transition stems from the Centers for Medicare & Medicaid Services (CMS) Medicaid Managed Care Final Rule that was issued last summer, which will limit federal reimbursement for residential treatment of Medicaid recipients to 15 days. In response to that rule, and specifically the provision related to the IMD exclusion, Pennsylvania aims to better position ourselves in submitting a 1115 waiver to CMS related to the IMD exclusion. The 1115 waiver application requires the use of the ASAM tool. This issue surrounding the IMD exclusion is not the only reason for making the change, however. The newly acquired treatment data system is already equipped with the ASAM continuum of care which will make this new system more usable with fewer modifications, which limits the risk of future system maintenance issues. Additionally, because the ASAM is currently utilized for placement decisions related to adolescents, and by many commercial insurance providers for both adults as well as adolescents, converting to this tool will create consistency for providers and payers across the treatment system.
While there are multiple advantages to this conversion, we understand that it will not come without its challenges. We have a team of employees who are currently in the process of establishing a strategic plan for transitioning from the PCPC to the ASAM and will be gathering input from stakeholders and establish a workable process that moves us to the use of the ASAM over time, with the goal of full implementation occurring by July 2018. I will continue to keep you posted on the progress and impacts of this effort. I would ask that this become a standing agenda item in our meetings with your membership.
|1/18/2017 10:19 AM||PA Hepatitis C Epidemiologic Profile|
|12/22/2016 9:44 AM||FY 2017 Annual Synar Report |
The Pennsylvania Department of Drug and Alcohol Programs’ FY 2017 Annual Synar Report is currently available for review on the agency’s website: http://www.ddap.pa.gov/Pages/Annual-Reports.aspx . This report is submitted to SAMHSA as a requirement of the Substance Abuse Block Grant and provides information about initiatives aimed at decreasing youth access to tobacco.
In addition to the DDAP website, this report along with the full SAPT Block Grant Application, is available on WebBGAS. To access the block grant reports, log in as "citizenpa" and use "citizen" as your password. Comments can be made at: http://www.ddap.pa.gov/Pages/Contact_Request_Form.aspx
|10/26/2016 3:30 PM||Free Downloadable Media Literacy Curricula for Middle and High School|
DEPARTMENT OF DRUG AND ALCOHOL PROGRAMS ANNOUNCES:
FREE DOWNLOADABLE MEDIA LITERACY CURRICULA
(MIDDLE AND HIGH SCHOOL)
The Department of Drug and Alcohol Programs is pleased to announce that it is making available free, downloadable educational curricula to prevention providers and educators for the purpose of teaching digital and media literacy to middle and high-school students.
The “Media Straight Up! Critical Thinking Skills for Pennsylvania’s Youth” (middle school level) and “Pushing Back: Responding to Representation of Drugs and Alcohol in Popular Culture” (high school level) are curricula that provide specific instructional strategies for raising young people’s awareness and critical thinking skills in responding to mass and social media messages that depict alcohol, tobacco, prescription and illegal drug use. Digital and media literacy skills help students to evaluate the quality and accuracy of what they see, hear and read. They help them recognize how and why media messages appeal to their audience, sharpening awareness of unstated but implied messages.
These media literacy curricula are a resource for any prevention specialist or educator to teach youth about the important skills of digital and media literacy which can contribute to a young person’s ability to understand how media messages affect their perceptions of drugs and alcohol, and may influence the choices they make. Prevention specialists, teachers, school counselors, and community leaders can each play a role in promoting critical thinking to our students about the unhealthy messages they hear and see daily throughout today’s media.
|8/22/2016 10:47 AM||What's Really at Stake - Public Service Campaign from the PA Gaming Control Board|
The Pennsylvania Gaming Control Board has launched a multi-faceted public service campaign to warn youth and parents about the dangers of attempting to gamble at a PA casino when underage. Feel free to disseminate this information on your website, social media sites, etc.
The campaign is titled “What’s Really at Stake” and is designed to raise awareness among youth that it is illegal to gain access to a casino floor in Pennsylvania under the age of 21, convey the numerous consequences of underage gambling, and demonstrate the link between underage gambling and other negative behaviors.
Additionally, the campaign provides messages to parents and friends who all too often facilitate gambling by an underager.
All funding for the What’s Really at Stake campaign is derived from confiscated winnings of voluntary or involuntary excluded patrons who illegally entered a Pennsylvania casino, gained winnings, and were caught in the facility.
|8/5/2016 1:21 PM||PA Open Beds |
Department of Drug and Alcohol Programs (DDAP) has released an innovative tool
to identify available treatment beds for individuals in residential treatment
programs. For more information or to register, you can visit the PA Open Beds page
on our website or email RA-DAOPENBEDS@pa.gov
or call Dan Miller at 717-736-7466.
|8/5/2016 1:20 PM||NALOXONE DISCOUNTS|
DDAP wishes to make our stakeholders
and the general public aware of two discount opportunities for the individual
purchase of naloxone with a prescription or through the use of the Pennsylvania
Physician General’s Standing Order:
the manufacturer of the “Evzio” naloxone auto-injector has announced that they
will minimize the out-of-pocket cost to patients and their family members and
caregivers by providing commercially-insured patients filing a prescription for
EVZIO with an out-of-pocket cost of less than $20 or, in most cases, $0, even
if their commercial insurance plan does not cover EVZIO. This reduced
price is through a pharmacy discount. Additional information about this
reduced price can be found at:
the manufacturer of Narcan Nasal Spray, has partnered with CVS Pharmacy to
offer individuals without insurance a $35 discount coupon available through the
local CVS pharmacy.
requests that this information be shared at large so that individuals are made
aware of these opportunities for obtaining naloxone at a reduced cost.
(Note: DDAP requests that
pharmaceutical companies or pharmacy discount programs notify the Department of
any additional price discounts as they become available so that they can be
added to this announcement.)